DLA PIPER LLP (US)

Lobbying for PRELUDE CORPORATION (PRELUDEDX) · Precision cancer diagnostics company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $70,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Health Issues

Improved patient access to cancer screening diagnostics.

Medicare/Medicaid

Policies related to Medicare reimbursement for cancer diagnostics.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.